An International Collaborative Study to Investigate Standardisation of Hirudin Potency

Summary

An international collaborative study has been carried out to investigate the reproducibility of hirudin assays in 13 laboratories using four recombinant hirudins and one natural, sulphated product. A simple assay procedure was proposed involving the titration of α-thrombin with inhibitor and measurement of residual activity using a chromogenic substrate. A standard α-thrombin preparation was supplied to ensure that this reagent was of uniform quality throughout the study. The method appeared to present no difficulties and laboratories reported similar potencies for the 5 hirudin samples, in line with expected values. This gave 200–222 Thrombin Inhibitory Units/ampoule (TIU/ampoule) of lyophilised hirudin, with geometric coefficient of variation (gcv) values ranging from 10.15–15.97%. This corresponds to specific activities of approximately 14,300–15,900 TIU/mg protein. This is close to the upper limit of previously reported values of specific activity. We conclude that the precision of this determination compared with the wider range of values in the literature (8,000–16,000 thrombin inhibitory units [TIU]/mg) results from the use of good quality standard α-thrombin by all laboratories. This study has important implications for hirudin standardisation.

• References

• 1 Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Haemostas 1991; 66: 141-152
• 2 Seemüller U, Dodt J, Fink E, Fritz H. Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins). In: Proteinase Inhibitors. Barrett AJ, Salvesen G. (eds). Amsterdam; Elsevier: 1986: 337-359
• 3 Harvey RP, Degryse E, Stefani L, Schamber F, Cazenave J-P, Courtney M, Tolstoshev P, Lecocq J-P. Cloning and expression of a cDNA coding for the anticoagulant hirudin from the blocksucking leech, Hirudo medicinalis . Proc Natl Acad Sci USA 1986; 83: 1084-1088
• 4 Märki WE, Wallis RB. The anticoagulant and antithrombotic properties of hirudins. Thromb Haemostas 1990; 64: 344-348
• 5 Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 1986; 25: 4622-4628
• 6 Stone SR, Hofsteenge J, Dennis S. Quantitative evaluation of the contribution of ionic interactions to the formation of the thrombin-hirudin complex. Biochemistry 1989; 28: 6857-6863
• 7 Folkers PJM, Clore GM, Driscoll PC, Doat J, Kohler S, Gronenborn AM. Solution structure of recombinant hirudin and the Lys 47 → Glu mutant: a nuclearmagnetic resonance and hybrid geometry-dynamical simulated annealing study. Biochemistry 1989; 28: 2601-2617
• 8 Haruyama H, Wuthrick K. Conformation of recombinant desulfate hirudin in aqueous solution determined by nuclear magnetic resonance. Biochemistry 1989; 28: 4301-4312
• 9 Grütter MG, Priestle JP, Rahuel J, Grossenbacher H, Bode U, Hofsteenge J, Stone SJ. Crystal structure of thrombin-hirudin complex: a novel model of serine protease inhibition. EMBO J 1990; 9: 2361-2365
• 10 Rydel TJ, Ravichrandran KG, Tulisky A, Bode W, Huber R, Fenton JW, Roitsch C. The structure of a complex of recombinant hirudin and human-α-thrombin. Science 1990; 249: 277-280
• 11 Stone SR, Hofsteenge J. Basis for the reduced affinity of β_T- and gamma_T-thrombin for hirudin. Biochemistry 1991; 30: 3950-3955
• 12 Hofsteenge J, Stone SR, Donella-Deana A, Pinna LA. The effect of substituting phosphotyrosine for sulphotyrosine on the activity of hirudin. Eur J Biochem 1990; 188: 55-59
• 13 Gaffney PJ, Heath AB, Fenton JW. A collaborative study to establish an International standard for alpha-thrombin. Thromb Haemostas 1992; 67: 424-427
• 14 Finney DJ. In: Statistical Methods in Biological Assay. 3.. London: Griffin and Co; 1978
• 15 Kirkwood TBL. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-909
• 16 Griessbach U, Stürzebecher J, Markwardt F. Assay of hirudin in plasma using a chromogenic thrombin substrate. Thromb Res 1985; 37: 347-350
• 17 Markwardt F, Stürzebecher J, Walsmann P. The hirudin standard. Thromb Res 1990; 59: 395-400
• 18 Stürzebecher J. Methods for determination of hirudin. Semin Thromb Hemostas 1991; 17: 99-102
• 19 Spinner S, Scheffauer F, Maschler R, Stoffler G. A hirudin catching ELISA for quntitating the anticoagulant in biological fluids. Thromb Res 1988; 51: 617-625
• 20 Walenga JM, Hoppensteadt D, Koza M, Pifarre R, Fareed J. Comparative studies on various assays for the laboratory evaluation of r-hirudin. Semin Thromb Hemostas 1991; 17: 103-112
• 21 Jameson GW, Roberts DV, Adams RW, Kyle WSA, Elmore DT. Determination of the operational molarity of solutions of bovine α-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. Biochem J 1973; 131: 107-117
• 22 Degryse E. Determination of the specific activity of recombinant hirudin. Thromb Res 1990; 60: 433-443
• 23 Degryse E, Ebel C. Influence of storage conditions on the activity of recombinant hirudin. Thromb Res 1991; 61: 87-89
• 24 Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP. Experimental studies on a recombinant hirudin CGP 39393. Thromb Haemostas 1991; 65: 355-359